Anti-heat shock protein 90β antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis

Journal of Neurochemistry

Volumn 95, Issue 2, 2005, Pages 349-360

  Cid, Cristina ^a   Álvarez Cermeño, Jose C ^a   Salinas, Matilde ^a   Alcázar, Alberto ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Complement 1 esterase inhibitor; Complement activation; Oligodendrocyte precursor cells

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN G ANTIBODY; PROTEIN ANTIBODY;

ADULT; ANIMAL CELL; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONFOCAL MICROSCOPY; DEMYELINATING DISEASE; EMBRYO; HUMAN; IMMUNOPRECIPITATION; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PRIORITY JOURNAL; RAT; REMYELINIZATION; WESTERN BLOTTING;

ADULT; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; BLOTTING, WESTERN; CELL DEATH; CELLS, CULTURED; COMPLEMENT ACTIVATION; COMPLEMENT C1 INACTIVATOR PROTEINS; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, CONFOCAL; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; OPTIC NERVE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS;

EID: 26844489800     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03371.x     Document Type: Article

References (38)

1. Armstrong R. C., Dom H. H., Kufta C. V., Friedman E. and Dubois-Dalcq M. E. (1992) Pre-oligodendrocytes from adult human CNS. J. Neurosci. 12, 1538-1547.
2. Barres B. A. and Raff M. C. (1993) Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature. 361, 258-260.
3. Barres B. A., Hart I. K., Coles H. S. R., Burne J. F., Voyvodic J. T., Richardson W. D. and Raff M. C. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70, 31-46.
4. Bergamaschini L. and Cicardi M. (2003) Recent advances in the use of C1 inhibitor as a therapeutic agent. Mol. Immunol. 40, 155-158.
5. Blakemore W. F. and Keirstead H. S. (1999) The origin of remyelinating cells in the central nervous system. J. Neuroimmunol. 98, 69-76.
6. Bottenstein J. E. and Sato G. H. (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl Acad. Sci. USA 76, 514-517.
7. Chang A., Tourtellotte W. W., Rudick R. and Trapp B. D. (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346, 165-200.
8. Cid C., Álvarez-Cermeño J. C., Camafeita E., Salinas M. and Alcázar A. (2004) Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture. Implications for demyelination in multiple sclerosis. FASEB J. 18, 409-411.
9. Compston A. and Coles A. (2002) Multiple sclerosis. Lancet. 359, 1221-1231.
10. Conroy S. E. and Latchman D. S. (1996) Do heat shock proteins have a role in breast cancer? Br. J. Cancer 74, 717-721.
11. Eisenbarth G. S., Walsh F. S. and Nirenberg M. (1979) Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl Acad. Sci. USA 76, 4913-4917.
12. Ffrench-Constant C. and Raff M. C. (1986) Proliferating bipotential glial progenitor cells in adult rat optic nerve. Nature. 319, 499-502.
13. Franklin R. J. (2002) Why does remyelination fail in multiple sclerosis? Nat. Rev. Neurosci. 3, 705-714.
14. Hayem G., De Brand M., Palazzo E., Rouxd S., Combe B., Eliaou J. F., Sany J., Kahn M. F. and Meyer O. (1999) Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann. Rheum. Dis. 58, 291-296.
15. Kondo T. and Raff M. (2000) Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science. 289, 1754-1757.
16. Levine J. M., Reynolds R. and Fawcett J. W. (2001) The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 24, 39-47.
17. Lock C., Hermans G., Pedotti R. et al. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508.
18. McDonald W. I., Compston A., Edan G. et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50, 121-127.
19. Mycko M. P., Papoian R., Boschert U., Raine C. S. and Selmaj K. W. (2003) cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain. 126, 1048-1057.
20. Noseworthy J. H., Lucchinetti C., Rodriguez M. and Weinshenker B. G. (2000) Multiple sclerosis. N. Engl. J. Med. 28, 938-952.
21. Piddelesden S. J. and Morgan B. P. (1993) Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J. Neuroimmunol. 48, 169-176.
22. Piddlesden S. J., Lassmann H., Zimprich F., Morgan B. P. and Linington C. (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143, 555-564.
23. Raff M. C., Abney E. R., Cohen J., Lindsay R. and Noble M. (1983b) Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J. Neurosci. 3, 1289-1300.
24. Raff M. C., Miller R. H. and Noble M. (1983a) A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 303, 390-396.
25. Roy N. S., Wang S., Harrison-Restelli C., Benraiss A., Fraser R. A. R., Gravel M., Braun P. E. and Goldman S. A. (1999) Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J. Neurosci. 19, 9986-9995.
26. Scolding N. J., Morgan B. P., Houston W. A. J., Linington C., Campbell A. K. and Compston D. A. S. (1989) Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement. Nature. 339, 620-622.
27. Scolding N. J., Morgan B. P., Campbell A. K. and Compston D. A. S. (1990) Complement mediated serum cytotoxicity against oligodendrocytes: a comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage. J. Neurol. Sci. 97, 155-162.
28. Scolding N. J., Rayner P. J. and Compston D. A. S. (1999) Identification of A2B5-positive putative oligodendrocyte progenitor cells and A2B5-positive astrocytes in adult human white matter. Neuroscience. 89, 1-4.
29. Scolding N. J., Rayner P. J., Sussman J., Shaw C. and Compston D. A. S. (1995) A proliferative adult human oligodendrocyte progenitor. Neuroreport. 6, 441-445.
30. Shi J., Marinovich A. and Barres B. A. (1998) Purification and characterization of adult oligodendrocyte precursor cells from the rat optic nerve. J. Neurosci. 15, 4627-4636.
31. Sidera K., Samiotaki M., Yfanti E., Panayotou G. and Patsavoudi E. (2004) Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system. J. Biol. Chem. 279, 45 379-45 388.
32. Sommer I. and Schachner M. (1981) Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev. Biol. 83, 311-327.
33. Spiegel K., Emmmerling M. R. and Barnum S. R. (1998) Strategies for inhibition of complement activation in the treatment of neurodegenerative diseases, in Neuroinflammation: Mechanism and Management (Wood P. L., ed.), pp. 129-176. Humana Press, Totowa, NJ.
34. Temple S. and Raff M. C. (1986) Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions. Cell. 44, 773-779.
35. Wolswijk G. (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 15, 601-609.
36. Wolswijk G. (2002) Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain. 125, 338-349.
37. Wren D. R. and Noble M. (1989) Oligodendrocytes and oligodendrocytes/ type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc. Natl Acad. Sci. USA 86, 9025-9029.
38. Zajicek J., Wing M., Skepper J. and Compston A. (1995) Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system. Lab. Invest. 73, 128-138.